Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Short Interest Update

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 100 shares, a decrease of 98.4% from the March 31st total of 6,200 shares. Based on an average daily trading volume, of 21,900 shares, the short-interest ratio is currently 0.0 days.

Rocket Pharmaceuticals Stock Performance

Shares of NASDAQ RCKTW traded up $0.02 during trading hours on Thursday, hitting $0.11. 6,589 shares of the stock were exchanged, compared to its average volume of 24,998. The company’s fifty day simple moving average is $0.24 and its two-hundred day simple moving average is $0.29. Rocket Pharmaceuticals has a 1-year low of $0.05 and a 1-year high of $0.50.

Rocket Pharmaceuticals Company Profile

Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.